BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

294 related articles for article (PubMed ID: 23239193)

  • 1. Is DCIS breast cancer, and how do I treat it?
    Bijker N; Donker M; Wesseling J; den Heeten GJ; Rutgers EJ
    Curr Treat Options Oncol; 2013 Mar; 14(1):75-87. PubMed ID: 23239193
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Ductal carcinoma in situ (DCIS) of the breast: evolving perspectives.
    Sakorafas GH; Tsiotou AG
    Cancer Treat Rev; 2000 Apr; 26(2):103-25. PubMed ID: 10772968
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Ductal carcinoma in situ of the breast: a systematic review of incidence, treatment, and outcomes.
    Virnig BA; Tuttle TM; Shamliyan T; Kane RL
    J Natl Cancer Inst; 2010 Feb; 102(3):170-8. PubMed ID: 20071685
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mammographically detected, clinically occult ductal carcinoma in situ treated with breast-conserving surgery and definitive breast irradiation.
    Solin LJ; McCormick B; Recht A; Haffty BG; Taylor ME; Kuske RR; Bornstein BA; McNeese M; Schultz DJ; Fowble BL; Barrett W; Yeh IT; Kurtz JM; Amalric R; Fourquet A
    Cancer J Sci Am; 1996; 2(3):158-65. PubMed ID: 9166516
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Treatment for ductal carcinoma in situ in an Asian population: outcome and prognostic factors.
    Chuwa EW; Tan VH; Tan PH; Yong WS; Ho GH; Wong CY
    ANZ J Surg; 2008; 78(1-2):42-8. PubMed ID: 18199204
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Women with Low-Risk DCIS Eligible for the LORIS Trial After Complete Surgical Excision: How Low Is Their Risk After Standard Therapy?
    Pilewskie M; Olcese C; Patil S; Van Zee KJ
    Ann Surg Oncol; 2016 Dec; 23(13):4253-4261. PubMed ID: 27766556
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [The treatment of ductal carcinoma in situ (DCIS) of the breast].
    Westenberg AH; Rutgers EJ; Peterse JL; Hendriks JH; Beex LV; van Tienhoven G
    Ned Tijdschr Geneeskd; 2003 Nov; 147(44):2157-61. PubMed ID: 14626831
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Diagnosis and management of ductal carcinoma in situ (DCIS).
    Virnig BA; Shamliyan T; Tuttle TM; Kane RL; Wilt TJ
    Evid Rep Technol Assess (Full Rep); 2009 Sep; (185):1-549. PubMed ID: 20629475
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Ductal carcinoma in situ, complexities and challenges.
    Leonard GD; Swain SM
    J Natl Cancer Inst; 2004 Jun; 96(12):906-20. PubMed ID: 15199110
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Treatment of ductal carcinoma in situ after excision: would a prophylactic paradigm be more appropriate?
    Punglia RS; Schnitt SJ; Weeks JC
    J Natl Cancer Inst; 2013 Oct; 105(20):1527-33. PubMed ID: 24068769
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Risk of subsequent invasive breast cancer after a diagnosis of ductal carcinoma in situ (DCIS).
    Cheung S; Booth ME; Kearins O; Dodwell D
    Breast; 2014 Dec; 23(6):807-11. PubMed ID: 25270228
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Management of women with ductal carcinoma in situ of the breast: a population-based study.
    Verkooijen HM; Fioretta G; De Wolf C; Vlastos G; Kurtz J; Borisch B; Schäfer P; Spiliopoulos A; Sappino AP; Renella R; Pittet B; Schmid De Gruneck J; Wespi Y; Neyroud-Caspar I; Bouchardy C
    Ann Oncol; 2002 Aug; 13(8):1236-45. PubMed ID: 12181247
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Ductal carcinoma in situ of the breast - Long term results from a twenty-year cohort.
    Co M; Kwong A
    Cancer Treat Res Commun; 2018; 14():17-20. PubMed ID: 30104003
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Treatment of ductal carcinoma in situ: an uncertain harm-benefit balance.
    Prescrire Int; 2013 Dec; 22(144):298-303. PubMed ID: 24600734
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Targeted Intraoperative Radiotherapy for the Management of Ductal Carcinoma In Situ of the Breast.
    Rivera R; Banks A; Casillas-Lopez A; Rashtian A; Lewinsky B; Sheth P; Hovannesian-Larsen L; Brousseau D; Iyengar G; Holmes DR
    Breast J; 2016; 22(1):63-74. PubMed ID: 26534876
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A retrospective alternative for active surveillance trials for ductal carcinoma in situ of the breast.
    Van Bockstal MR; Agahozo MC; Koppert LB; van Deurzen CHM
    Int J Cancer; 2020 Mar; 146(5):1189-1197. PubMed ID: 31018242
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Ductal carcinoma in situ: a disease entity that merits more recognition.
    Dereere E; Papadimitriou K; Tjalma W; Altintas S
    Minerva Chir; 2015 Aug; 70(4):231-9. PubMed ID: 25916193
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Conservative treatment of breast ductal carcinoma in situ: results of an Italian multi-institutional retrospective study.
    Vidali C; Caffo O; Aristei C; Bertoni F; Bonetta A; Guenzi M; Iotti C; Leonardi MC; Mussari S; Neri S; Pietta N
    Radiat Oncol; 2012 Oct; 7():177. PubMed ID: 23098066
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Ten-year risk of diagnostic mammograms and invasive breast procedures after breast-conserving surgery for DCIS.
    Nekhlyudov L; Habel LA; Achacoso N; Jung I; Haque R; Collins LC; Schnitt SJ; Quesenberry CP; Fletcher SW
    J Natl Cancer Inst; 2012 Apr; 104(8):614-21. PubMed ID: 22491230
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Optimal management of ductal carcinoma in situ of the breast.
    Sakorafas GH; Farley DR
    Surg Oncol; 2003 Dec; 12(4):221-40. PubMed ID: 14998563
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.